Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Babjuk

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Casopis Lekaru Ceskych|October 27, 1998
[Treatment of localized carcinoma of the prostate]J Jarolím, V Vachalovský, J Novák, et al.
Anticancer Research|October 15, 2010
Importance of miR-20a expression in prostate cancer tissueM Pesta, J Klecka, V Kulda, et al.
European Urology|May 10, 2002
Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladderM Babjuk, M Kostírová, K Mudra, et al.
Anticancer Research|March 25, 2010
Differential display code 3 (DD3/PCA3) in prostate cancer diagnosisJ Klecka, L Holubec, M Pesta, et al.
Casopis Lekaru Ceskych|November 21, 2007
[Analysis of results of percutaneous nephrolithotomies]P Macek, K Novák, T Hanus, et al.
Neoplasma|July 30, 2016
MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detectionS Pospisilova, E Pazourkova, A Horinek, et al.
International Urology and Nephrology|October 28, 2003
The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcomeM Babjuk, V Soukup, J Mares, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]L Nison, P Colin, M Remzi, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 11, 2014
Cancer incidence and mortality in the Czech RepublicL Dusek, J Muzik, D Maluskova, et al.
European Urology|May 25, 2020
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS"Marc-Oliver Grimm, Antoine G van der Heijden, Marc Colombel, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Casopis Lekaru Ceskych|October 27, 1998
[Treatment of localized carcinoma of the prostate]J Jarolím, V Vachalovský, J Novák, et al.
Anticancer Research|October 15, 2010
Importance of miR-20a expression in prostate cancer tissueM Pesta, J Klecka, V Kulda, et al.
European Urology|May 10, 2002
Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladderM Babjuk, M Kostírová, K Mudra, et al.
Anticancer Research|March 25, 2010
Differential display code 3 (DD3/PCA3) in prostate cancer diagnosisJ Klecka, L Holubec, M Pesta, et al.
Casopis Lekaru Ceskych|November 21, 2007
[Analysis of results of percutaneous nephrolithotomies]P Macek, K Novák, T Hanus, et al.
Neoplasma|July 30, 2016
MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detectionS Pospisilova, E Pazourkova, A Horinek, et al.
International Urology and Nephrology|October 28, 2003
The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcomeM Babjuk, V Soukup, J Mares, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]L Nison, P Colin, M Remzi, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|December 11, 2014
Cancer incidence and mortality in the Czech RepublicL Dusek, J Muzik, D Maluskova, et al.
European Urology|May 25, 2020
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS"Marc-Oliver Grimm, Antoine G van der Heijden, Marc Colombel, et al.
Pageof 6